Cytodyn Inc (CYDY)

[Saltz]

Misiu, I agree with most of your thought process. Believe me I'm very bullish. However, when you state " you don't see any reason why the FDA wouldn't reduce to 30 patients" understand the FDA has a reason for anything and everything. It doesn't make sense from our perspective or perhaps the companies perspective. That IMO is why Nader and company requested a face to face. They want transparency - what the hurdles are and what they may not be taking into account from the FDA's point of view. Unclear understanding and communication with the FDA are why timelines are cintinually lengthened and investor confidence is tested resulting in an erosion in SP. The story appears to be a home run - minimum10 bagger but the FDA controls how long and how much the cost will be. That is the biggest wild card with our investment and we have absolutely zero control. So when you say no reason there CAN always be a reason. In this particular scenario I think the data is strong enough to warrant positive news from the FDA face to face and that will surprise the the consensus. Fingers crossed Misiu - I have a tremendous amount of confidence in the CYDY team and Pro-140.